Search results for "mucositis"

showing 10 items of 103 documents

An observational retrospective study of odontogenic cyst´s and tumours over an 18-year period in a Portuguese population according to the new WHO Hea…

2020

Background Odontogenic cysts and tumours of the jaws represent one of the most prevalent groups of oral-maxillofacial lesions. We aimed to evaluate the clinical and pathological characteristics of a cohort of odontogenic cysts (OC) and odontogenic tumours (OT) of the jaws in a Portuguese population. Material and Methods This observational retrospective study analysed patients diagnosed with either an OC or OT of the jaws at a central hospital of Oporto, Portugal, between 1988 and 2006. Data collected from patients’ files included demographic, clinical, radiological and histopathological information. Recurrence was evaluated using univariate and multivariate analysis. Results The sample cons…

AdultMalemedicine.medical_specialtyMultivariate analysisWorld Health OrganizationLesionYoung Adultpd-l1Odontogenic cystHumansMedicineGeneral DentistryPathologicalUNESCO:CIENCIAS MÉDICASRetrospective StudiesRadicular CystOral Medicine and PathologyPortugalbusiness.industryResearchRetrospective cohort studyMiddle Agedoral cancermedicine.diseaseDermatologystomatognathic diseasespd1OtorhinolaryngologyHead and Neck NeoplasmsOdontogenic CystsCohortFemaleSurgeryObservational studyimmunotherapyNeoplasm Recurrence Localmedicine.symptombusinessoral mucositisMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Changes in microflora in dental plaque from cancer patients undergoing chemotherapy and the relationship of these changes with mucositis: a pilot stu…

2015

Background: To assess changes in oral microflora in dental plaque from cancer patients within 7 days of the first course of chemotherapy, and the relationship of the changes with mucositis. Material and Methods: Thirty cancer patients, divided into a test group undergoing chemotherapy and a control group no undergoing chemotherapy, were enrolled in this pilot study. Oral microflora were cultured from three samples of dental plaque at t0 (before chemotherapy), t1 (1 day after chemotherapy) and t2 (7 days after chemotherapy). Single and crossed descriptive analyses were used to establish prevalence, and the χ 2 test was used to establish the statistical significance of the differences observe…

AdultMalemedicine.medical_specialtyTime Factorsdental plaquemedicine.medical_treatmentDentistryAntineoplastic AgentsPilot ProjectsOdontologíaDental plaquechemotherapyoral microflorastomatognathic systemNeoplasmsStatistical significanceInternal medicinemedicineMucositisHumansGeneral DentistryStomatitisStomatitisChemotherapyOral Medicine and PathologyBacteriabiologybusiness.industryResearchCancerMiddle Agedmedicine.diseasebiology.organism_classification:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludBacterial Loadoral microflora; dental plaque; cancer patients; chemotherapystomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologyActinobacillusUNESCO::CIENCIAS MÉDICASFemaleSurgeryFusobacterium nucleatumbusinesscancer patients
researchProduct

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo…

2001

To study the efficacy of coumarin/troxerutine for the protection of salivary glands and mucosa during irradiation. Design: Prospective, randomized, placebo-controlled, double-blind trial. Setting: University hospital, Germany. Patients: 48 patients who had radiotherapy to the head and neck. Main outcome measures: Salivary gland scintigraphy and acute side-effects of radiotherapy (Radiation Therapy Oncology Group (RTOG) score). Results: 23 patients (11 experimental, 12 placebo) completed the study. The global efficacy measure combining scintigraphy and RTOG score favoured the experimental arm (P= 0.07). The RTOG score showed significantly fewer acute side-effects of radiation in the experime…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRadiation-Protective AgentsPlaceboGastroenterologyXerostomiaSalivary GlandsSialadenitislaw.inventionRandomized controlled trialDouble-Blind MethodlawCoumarinsInternal medicinemedicineMucositisHumansProspective StudiesProspective cohort studyRadiation InjuriesRadionuclide ImagingAgedSodium Pertechnetate Tc 99mbusiness.industryHead and neck cancerMouth MucosaMiddle Agedmedicine.diseaseSialadenitisSurgeryRadiation therapyDrug CombinationsHydroxyethylrutosideTreatment OutcomeOtorhinolaryngologyEpidermoid carcinomaHead and Neck NeoplasmsSurgeryFemaleOral SurgeryCranial IrradiationRadiopharmaceuticalsbusinessThe British journal of oralmaxillofacial surgery
researchProduct

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study

2007

Abstract Background The objective of this study is to evaluate the efficacy and toxicity of the liposome-encapsulated doxorubicin (TLC D-99) plus cyclophosphamide (CTX) as first-line treatment of metastatic breast cancer in light of the potential cardioprotective effect of TLC D-99 as compared with conventional doxorubicin. Materials and methods Sixty-seven patients as defined according Simon's two-stage phase II design were enrolled. They received TLC D-99 at the dosage of 60 mg/m2 plus CTX 600 mg/m2, with cycles repeated every 3 weeks. Cardiac function was assessed by ultrasonography at baseline and every two cycles. Results The principal characteristics of the 67 enrolled patients were a…

Adultmedicine.medical_specialtySkin NeoplasmsCyclophosphamideSettore MED/06 - Oncologia MedicaPhases of clinical researchBreast NeoplasmsSoft Tissue NeoplasmsAsymptomaticGastroenterologyDrug Delivery SystemsBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineMucositisHumansAntineoplastic Agents AlkylatingCyclophosphamideAgedAntibiotics AntineoplasticPerformance statusbusiness.industryHematologyMiddle Agedmedicine.diseasedoxorubicin cyclophosphamide breast cancerMetastatic breast cancerSurgeryOncologyDoxorubicinLiposomesToxicityCarcinoma Squamous CellFemalemedicine.symptombusinessmedicine.drug
researchProduct

Oral rehabilitation with dental implants in patients with recessive dystrophic epidermolysis bullosa : a retrospective study with 2-15 years of follo…

2019

Background Epidermolysis bullosa (EB) comprises a group of hereditary disorders characterized by mechanical fragility of the skin and mucous membranes, with the development of blisters and vesicles in response to minimum tissue friction. Recessive dystrophic epidermolysis bullosa (RDEB) with generalized involvement is the most common subtype in the oral cavity. The present study was carried out to investigate dental implant survival, peri-implant tissue condition, patient satisfaction, and the impact of treatment upon the quality of life of patients with RDEB rehabilitated with implants and full-arch implant-supported prostheses. Material and Methods Thirteen patients with RDEB underwent de…

Adultmedicine.medical_treatmentDentistry03 medical and health sciencesYoung Adult0302 clinical medicinePatient satisfactionmedicineMucositisMaxillaHumansJaw EdentulousDental Restoration FailureDental implantGeneral DentistrySurvival rateRetrospective StudiesDental ImplantsOral Medicine and Pathologybusiness.industryResearchDental prosthesisDental Implantation EndosseousEpidermolysis bullosa dystrophica030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Epidermolysis Bullosa DystrophicaTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgeryEpidermolysis bullosaImplantDental Prosthesis Implant-SupportedbusinessFollow-Up Studies
researchProduct

SNPs and taxane toxicity in breast cancer patients

2014

Aim: In order to identify genetic variants associated with taxanes toxicity, a panel with 47 SNPs in 20 genes involved in taxane pathways was designed. Patients & methods: Genomic DNA of 113 breast cancer patients was analyzed (70 taking docetaxel, 43 taking paclitaxel). Results: Two SNPs associated with docetaxel toxicity were identified: CYP3A4*1B with infusion-related reactions; and ERCC1 Gln504Lys with mucositis (p ≤ 0.01). Regarding paclitaxel toxicity: CYP2C8 HapC and CYP2C8 rs1934951 were associated with anemia; and ERCC1 Gln504Lys with neuropathy (p ≤ 0.01). Conclusion: Genes involved in DNA repair mechanisms and reactive oxygen species levels influence taxane toxicity in cance…

Bridged-Ring CompoundsMucositisOncologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsPaclitaxelmedicine.medical_treatmentBreast NeoplasmsDocetaxelPharmacologyPolymorphism Single Nucleotidechemistry.chemical_compoundBreast cancerInternal medicineGeneticsMucositisCytochrome P-450 CYP3AHumansMedicineGenetic Association StudiesAgedPharmacologyChemotherapyTaxanebusiness.industryCancerMiddle AgedEndonucleasesmedicine.diseaseDNA-Binding ProteinsDocetaxelPaclitaxelchemistryMolecular MedicineFemaleTaxoidsERCC1businessmedicine.drugPharmacogenomics
researchProduct

68 O - Maintenance low-dose (LD) oral idarubicin (oIDA) in elderly patients (pts) with acute myelogeneous leukemia (AML)

1996

IDA by i.v. route. especially in combination with cytosine arabinoside (Ara-C). proved quite effective for intensive chemotherapy of AML However, persisting controversies on aggressive/intensive versus “ottenvated” regimens for elderly AML pts emphasize the interest of olDA in this latter setting (ct M.R. Howard et al and M.J. Keating. Clin. Drug Invest. 1995; 9. Suppl. 2: 16–38) A 69% complete response (CR) rate was recentty reported (F. Leoni et al Br. J. Hoematol 1995; 90: 169–174) among 25 elderly AML pts (> 60 yrs old) with an “attenuated” dose of IDA, i.e. 8 mg/m2 i.v. d, 1. 3, and 5. plus Ara-C 200 mg/m2 by continuous i.v. infusion (ClV) d, 1–7, and etoposide (VP-16) 60 mg/m2 i.v. d,…

Cancer Researchmedicine.medical_specialtyNauseabusiness.industryInduction chemotherapymedicine.diseaseGastroenterologyMinimal residual diseaseSurgeryRegimenOncologyOral administrationInternal medicinemedicineMucositisIdarubicinmedicine.symptombusinessEtoposidemedicine.drugEuropean Journal of Cancer
researchProduct

2021

IntroductionImmune checkpoint inhibitors (ICI) are increasingly being used to treat numerous cancer types. Together with improved recognition of toxicities, this has led to more frequent identification of rare immune-related adverse events (irAE), for which specific treatment strategies are needed. Neutropenia is a rare hematological irAE that has a potential for a high mortality rate because of its associated risk of sepsis. Prompt recognition and timely treatment of this life-threatening irAE are therefore critical to the outcome of patients with immune-related neutropenia.MethodsThis multicenter international retrospective study was conducted at 17 melanoma centers to evaluate the clinic…

Cancer Researchmedicine.medical_specialtySide effectbusiness.industrymedicine.medical_treatmentImmunosuppressionRetrospective cohort studyNeutropeniamedicine.diseaseMetamizoleSepsisOncologyInternal medicineMucositisMedicinebusinessAdverse effectmedicine.drugFrontiers in Oncology
researchProduct

Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume anal…

2015

Background The purpose of this study was to assess predictors of mucositis in oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc radiotherapy (VMAT) +/− chemotherapy. Methods Fifty patients were evaluated. Statistical analysis was performed for the following parameters as potential predictors of mucositis ≥ G2: total oral mucosa and oral mucosa minus target high-low radiation dose regions (planning target volumes [PTVs]), mean dose (Dmean), maximum dose (Dmax), chemotherapy, weight loss, and dysphagia. Results Mucositis ≥ G2 was found to be statistically related to chemotherapy, weight loss, dysphagia ≥ G2, total oral mucosa Dmean ≥50 Gy and Dmax ≥65 …

Chemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerOral cavitymedicine.diseaseDysphagia030218 nuclear medicine & medical imagingSurgeryRadiation therapy03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureOtorhinolaryngologyWeight loss030220 oncology & carcinogenesisMucositisMedicinemedicine.symptomOral mucosabusinessNuclear medicineHead & Neck
researchProduct

Long-term outcomes of oral rehabilitation with dental implants in HIV-positive patients: A retrospective case series

2016

Background: The existing information on oral rehabilitations with dental implants in VIH-positive patients is scarce and of poor quality. Moreover, no long-term follow-up studies are available. Hence, the aims of this study were to describe the long-term survival and success rates of dental implants in a group of HIV-positive patients and to identify the most common postoperative complications, including peri-implant diseases. Material and Methods: A retrospective case series of HIV-positive subjects treated with dental implants at the School of Dentistry of the University of Barcelona (Spain) was studied. Several clinical parameters were registered, including CD4 cell count, viral load and…

Dental Restoration FailurePeri-implantitismedicine.medical_treatmentAlveolar Bone LossMEDLINEDentistryHIV InfectionsOdontologíaComplications (Medicine)Malalties de la boca03 medical and health sciences0302 clinical medicineMucositismedicineHumansDental Restoration Failure030212 general & internal medicineGeneral DentistryRetrospective StudiesDental ImplantsRehabilitationImplants dentalsbusiness.industryResearchDental implantsRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseasePeri-ImplantitisCiencias de la saludTreatment OutcomeComplicacions (Medicina)Mouth diseasesOtorhinolaryngologySpainUNESCO::CIENCIAS MÉDICASSurgeryImplantOral SurgeryHIV-positive personsbusinessPersones seropositivesViral loadFollow-Up Studies
researchProduct